Suspended

Turmeric as Treatment in Epilepsy

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being tested

Turmeric

Dietary Supplement
Who is being recruted

Congenital Abnormalities+23

+ Epileptic Syndromes

+ Brain Diseases

From 1 to 70 Years
+11 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Treatment Study

Interventional
Study Start: March 2018
See protocol details

Summary

Principal SponsorNYU Langone Health
Last updated: January 27, 2026
Sourced from a government-validated database.Claim as a partner

Study start date: March 1, 2018

Actual date on which the first participant was enrolled.

This is a single center open-label pilot clinical trial of patients 1-70 years of age with greater than 6 seizures per month diagnosed with Dravet Syndrome, Lennox-Gastaut Syndrome, Tuberous Sclerosis, or focal seizures. Twenty patients will be enrolled and treated with a stable dose of orally administered turmeric oil daily for 3 months. Patients and caregivers will be asked to keep a seizure diary logging all clinical events during the course of the study. Serum comprehensive metabolic panel, complete blood count with differential, and antiseizure medication levels, will be monitored at baseline, 1.5 months, and at the end of 3 months.

Official TitleTurmeric as Treatment in Epilepsy
NCT03254680
Principal SponsorNYU Langone Health
Last updated: January 27, 2026
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.

Treatment Study

These studies test new ways to treat a disease, condition, or health issue. The goal is to see if a new drug, therapy, or approach works better or has fewer side effects than existing options.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

From 1 to 70 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Congenital AbnormalitiesEpileptic SyndromesBrain DiseasesCentral Nervous System DiseasesEpilepsyEpilepsy, GeneralizedEpilepsies, MyoclonicHamartomaCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesNeoplasmsNeoplasms, Multiple PrimaryNeoplastic Syndromes, HereditaryNervous System MalformationsNervous System DiseasesNeurologic ManifestationsSeizuresSigns and SymptomsPathological Conditions, Signs and SymptomsTuberous SclerosisNeurodegenerative DiseasesHeredodegenerative Disorders, Nervous SystemNeurocutaneous SyndromesGenetic Diseases, InbornMalformations of Cortical DevelopmentMalformations of Cortical Development, Group ILennox Gastaut Syndrome

Criteria

1 inclusion criteria required to participate
Patients with greater than greater than six seizures per month diagnosed with Dravet Syndrome, Lennox-Gastaut Syndrome, Tuberous Sclerosis, or focal seizures followed at NYU CEC.
10 exclusion criteria prevent from participating
Patients expected to have changes to any medications or supplements during study period
exposure to any investigational agent in the month prior to study entry
pregnant or breast feeding women, positive pregnancy test
history of non-compliance
Show More Criteria

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Treatment Groups
Study Objectives

One single intervention group is designated in this study

This study does not include a placebo group 

Treatment Groups

Group I

Experimental
stable dose of orally administered turmeric oil

Study Objectives

Primary Objectives

Secondary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Suspended

New York University School of Medicine

New York, United StatesOpen New York University School of Medicine in Google Maps
SuspendedOne Study Center
Turmeric as Treatment in Epilepsy | PatLynk